Table 3.

Effect of EBRE on SGOT and SGPT (U/L) levels in streptozotocin-induced diabetic rat. Results are expressed as mean ± SEM; n = 3.

Groups	SGPT (U/L)	SGOT (U/L)
Control	167.7 ± 12.6	289.71 ± 20.9
Diabetic	251.3 ± 6.62###	494.71 ± 28.3###
Diabetic + glibenclamide	193.3 ± 5.56*	386.50 ± 32.8
Diabetic + EBRE (100 mg/kg)	170.8 ± 8.97**	331.60 ± 21.6**
Diabetic + EBRE (200 mg/kg)	187.6 ± 11.9*	354.00 ± 32.5*
Diabetic + EBRE (400 mg/kg)	193.1 ± 9.90*	399.42 ± 26.8

EBRE, Eryngium billardieri root extract; SGOT, serum glutamic-oxaloacetic transaminase; SGPT, serum glutamicpyruvic transaminase. *P < 0.05 and **P < 0.01 indicate significant differences compared to the diabetic group; ^###P < 0.001 versus control group.